EH
ESPR

Equitable Holdings’s Esperion Therapeutics ESPR Stock Holding History

Equitable Holdings’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.7K Sell
23,000
-3,176
-12% -$8.88K ﹤0.01% 1775
2026
Q1 		$96.9K Buy
26,176
+2,776
+12% +$8.79K ﹤0.01% 1650
2025
Q4 		$86.6K Hold
23,400
– – ﹤0.01% 1546
2025
Q3 		$62K Buy
+23,400
New +$45.3K ﹤0.01% 1504

Other funds holding ESPR

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Equitable Holdings's ESPR Position: Q2 2026 in Review

Equitable Holdings reduced its Esperion Therapeutics (ESPR) stake by 12% in Q2 2026, selling an estimated $8.88K and leaving 23,000 shares worth $72.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1775.

Equitable Holdings first reported a position in ESPR in Q3 2025 and has held it in 4 quarters since. The position peaked at $96.9K in Q1 2026. 192 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • Equitable Holdings held 23,000 shares of Esperion Therapeutics worth $72.7K as of Q2 2026.
  • Equitable Holdings sold 3,176 Esperion Therapeutics shares in Q2 2026, an estimated $8.88K.
  • Esperion Therapeutics made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1775 holding.
  • Equitable Holdings first reported a position in Esperion Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Equitable Holdings's Esperion Therapeutics position peaked at $96.9K in Q1 2026.
  • 192 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.